FDA Inspection 1009946 — UCLA Health, UCLA Blood & Platelet Center

UCLA Health, UCLA Blood & Platelet Center — FEI 3004048013

The FDA completed an inspection of UCLA Health, UCLA Blood & Platelet Center on April 26, 2017 in Los Angeles, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 26, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Los Angeles, CA (United States)